Literature DB >> 11469462

Left ventricular diastolic function in systemic sclerosis.

G Aguglia1, A Sgreccia, M L Bernardo, E Carmenini, M Giusti De Marle, A Reali, S Morelli.   

Abstract

OBJECTIVE: To assess left ventricular diastolic function in patients with systemic sclerosis (SSc) and to verify if a "primary" diastolic dysfunction might exist.
METHODS: In total 124 patients and 41 healthy subjects underwent complete echocardiographic examination. The following pulsed wave Doppler variables were evaluated: peak velocity during early filling (E), peak velocity during late atrial filling (A), E/A ratio, and early filling deceleration time.
RESULTS: Seventy-seven patients (62.1%) had conditions potentially affecting left ventricular diastolic function (Group A) and 47 patients (37.9%) formed a homogeneous group without cardiac involvement or other causes of abnormal diastolic function (i.e., systemic and/or pulmonary hypertension, ventricular hypertrophy, pericardial disease, systolic dysfunction, valvular heart disease, coronary artery disease) (Group B). The entire SSc population and Group A showed significant differences in the Doppler variables of diastolic function compared to the control group. No significant differences were found between Group B and controls.
CONCLUSION: In patients with SSc, left ventricular diastolic dysfunction was found only in patients with conditions potentially affecting left ventricular diastolic function. In patients without conditions potentially affecting left ventricular diastolic function no differences were seen in comparison with controls. SSc does not seem to cause "primary" diastolic abnormalities.

Entities:  

Mesh:

Year:  2001        PMID: 11469462

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

Review 2.  The heart in systemic sclerosis.

Authors:  Virginia Steen
Journal:  Curr Rheumatol Rep       Date:  2004-04       Impact factor: 4.592

3.  Detecting subclinical biventricular impairment in scleroderma patients by use of pulsed-wave tissue Doppler imaging.

Authors:  Ilknur Can; Ahmet Mesut Onat; Kudret Aytemir; Ali Akdogan; Kemal Ureten; Sedat Kiraz; Ihsan Ertenli; Lale Tokgozoglu; Ali Oto
Journal:  Tex Heart Inst J       Date:  2009

4.  Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables.

Authors:  Edoardo Rosato; Stefania Maione; Antonio Vitarelli; Anna Giunta; Luca Fontanella; Laura Tanturri de Horatio; Francesco Cacciatore; Michele Proietti; Simonetta Pisarri; Felice Salsano
Journal:  Rheumatol Int       Date:  2008-12-28       Impact factor: 2.631

5.  Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.

Authors:  Andriana I Papaioannou; Epaminondas Zakynthinos; Konstantinos Kostikas; Theodoros Kiropoulos; Angela Koutsokera; Athanasios Ziogas; Athanasios Koutroumpas; Lazaros Sakkas; Konstantinos I Gourgoulianis; Zoe D Daniil
Journal:  BMC Pulm Med       Date:  2009-05-09       Impact factor: 3.317

6.  Evaluation of Left Ventricular Diastolic Function by Echocardiography with Tissue Doppler in Systemic Sclerosis.

Authors:  Marina Carneiro de Freitas Roque; Percival D Sampaio-Barros; Ana Lucia Arruda; Sergio Barros-Gomes; Derly Becker; José Lazaro de Andrade; Ana Clara Tude Rodrigues
Journal:  Arq Bras Cardiol       Date:  2017-10-02       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.